These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39066582)

  • 1. Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China.
    Wang L; Xu X; Wang S; Li R; Zhang P
    Lab Med; 2024 Jul; ():. PubMed ID: 39066582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
    Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
    Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
    Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Blood Cell Alloimmunization in Korean Patients With Myelodysplastic Syndrome and Liver Cirrhosis.
    Kim HY; Cho EJ; Chun S; Kim KH; Cho D
    Ann Lab Med; 2019 Mar; 39(2):218-222. PubMed ID: 30430787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
    Singhal D; Kutyna MM; Chhetri R; Wee LYA; Hague S; Nath L; Nath SV; Sinha R; Wickham N; Lewis ID; Ross DM; Bardy PG; To LB; Reynolds J; Wood EM; Roxby DJ; Hiwase DK
    Haematologica; 2017 Dec; 102(12):2021-2029. PubMed ID: 28983058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.
    Adkins BD; Mehta A; Selesky M; Vittitow S; Smolkin ME; Ratcliffe SJ; Luckey CJ
    Transfusion; 2022 Dec; 62(12):2470-2479. PubMed ID: 36278434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
    Leal I; Dos Santos TD; Gilli S; Castilho L
    Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Extended Typing On Red Blood Cell Alloimmunization in Transfused Patients.
    Makarovska-Bojadzieva T; Velkova E; Blagoevska M
    Open Access Maced J Med Sci; 2017 Apr; 5(2):107-111. PubMed ID: 28507611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization.
    Sirianni MFM; Sippert E; Blos B; Gonçalves FRV; Hamerschlak N; Kutner J; Castilho L; Marti LC; Bonet-Bub C
    Transfus Med; 2022 Oct; 32(5):394-401. PubMed ID: 35778823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
    Leisch M; Weiss L; Lindlbauer N; Jungbauer C; Egle A; Rohde E; Greil R; Grabmer C; Pleyer L
    Leuk Res; 2017 Aug; 59():12-19. PubMed ID: 28535394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunization in myelodysplastic syndromes: Associations with sex, DAT-positivity, and increased transfusion needs.
    Rydén J; Clements M; Wikman A; Hellström-Lindberg E; Edgren G; Höglund P
    Transfusion; 2023 Nov; 63(11):2040-2051. PubMed ID: 37818926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion requirements and alloimmunization to red blood cell antigens in orthotopic liver transplantation.
    Uzuni A; El-Bashir J; Galusca D; Yeddula S; Nagai S; Yoshida A; Abouljoud MS; Otrock ZK
    Vox Sang; 2022 Mar; 117(3):408-414. PubMed ID: 34387366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell alloimmunization in transfused patients with bone marrow failure syndromes.
    Cohen D; Hartung H; Evans P; Friedman DF; Chou ST
    Transfusion; 2016 Jun; 56(6):1314-9. PubMed ID: 27080340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic Syndrome.
    Rozovski U; Ben-Tal O; Kirgner I; Mittelman M; Hareuveni M
    Isr Med Assoc J; 2015 Oct; 17(10):624-7. PubMed ID: 26665317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
    Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red Blood Cell Alloimmunization in Sickle Cell Disease Patients in Tanzania.
    Meda E; Magesa PM; Marlow T; Reid C; Roberts DJ; Makani J
    East Afr J Public Health; 2014; 11(2):775-780. PubMed ID: 28979065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis).
    Wong K; Lai WK; Jackson DE
    Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.